<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03258918</url>
  </required_header>
  <id_info>
    <org_study_id>F046400</org_study_id>
    <nct_id>NCT03258918</nct_id>
  </id_info>
  <brief_title>A Low-Carbohydrate Diabetes Prevention Program</brief_title>
  <official_title>A Mixed Methods Pilot Study of a Low-Carbohydrate Diabetes Prevention Program Among Individuals With Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Kidney Foundation of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will conduct a single-arm mixed methods pilot study to estimate weight loss
      as well as the percentage of participants who achieve 5% weight loss in a 16-week,
      Low-Carbohydrate Diabetes Prevention Program (LC-DPP). Weight loss from the pilot LC-DPP
      cohort will be compared to weight loss outcomes from previously published DPP studies. The
      investigators will also evaluate secondary outcomes including change in physical activity,
      mental health, psychosocial functioning, and hemoglobin A1c over the 6-month study period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An estimated 86 million US adults are have prediabetes, and, without intervention, many will
      develop T2DM over time. Fortunately, T2DM can be prevented or delayed through modest
      lifestyle changes. The landmark Diabetes Prevention Program (DPP) Trial demonstrated a 58
      percent reduction in the 3-year incidence of T2DM among individuals with prediabetes who
      achieved 7 percent body weight loss and engaged in routine physical activity. Accordingly,
      the DPP lifestyle intervention has been translated to communities across the United States,
      and, on average, participant weight change is 4 percent at 12 months. Thus, while group-based
      DPPs and can effectively promote weight loss among some participants, many DPP participants
      do not achieve the program goal of 5 to 7 percent body weight loss.

      Novel strategies to help participants achieve DPP weight-loss goals are important for two key
      reasons. First, weight loss is the primary driver of T2DM risk reduction, and the potential
      population health impact of the intervention is diminished when participants do not lose
      weight. Second, a growing number of health plans including Medicare offer coverage for the
      DPP and proposed reimbursement is largely tied to weight loss of at least 5 percent at 6
      months and 12 months. The DPP costs approximately $400-$500 per participant per year.
      Unfortunately, organizations that offer the DPP may be reimbursed for much less than this if
      participants do not meet weight loss goals, which could significantly compromise the
      program's long-term financial sustainability.

      One promising approach to help DPP participants lose more weight may be through a
      low-carbohydrate (LC) dietary intervention. Consistent with United States Dietary Guidelines
      (USDG), the original DPP Trial and translational group-based curricula recommend a low-fat
      (LF), calorie-restricted diet. However, there is growing controversy regarding the scientific
      merit of the Dietary Guidelines as well as growing recognition that LC diets may be more
      effective than LF diets for short-term weight loss and long-term weight maintenance. Notably,
      weight loss occurs without calorie restriction and LC diets improve blood glucose levels
      among individuals with T2DM and insulin resistance. Thus, a LC dietary intervention for
      prediabetes may augment individual weight loss and T2DM risk reduction while also maximizing
      third-party reimbursement.

      The aim of this mixed methods pilot study is to test whether a LC-DPP may lead to greater
      weight loss than the original DPP. In addition to objective measures of this program's
      preliminary efficacy (e.g. weight, HbA1c) the study team will also obtain qualitative
      participant feedback on the intervention. Taken together, these data will be used to improve
      the curriculum and inform a larger-scale intervention.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 11, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in body weight per participant over the study period</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured as percent body weight loss per participant</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of participants who achieve weight loss goal</measure>
    <time_frame>Baseline,12 months</time_frame>
    <description>Measured as percentange of participants who achieve 5% total body weight loss</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported weekly physical activity minutes</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will maintain a log of weekly physical activity minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical activity measured using the International Physical Activity Questionnaire</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will complete this validated survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in food cravings measured using the Control of Eating Questionnaire</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will complete this validated survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in stress eating measured using the Palatable Eating Motives Scale</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will complete this validated survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported health measured using the Global Health PROMIS Questionnaire</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will complete this validated survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in autonomous motivation measured using the Treatment Self-Regulation Questionnaire</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will complete this validated survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hemoglobin A1c</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured using a laboratory blood draw</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Session attendance</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Measured as the number of sessions attended per participant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study attrition</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Number of participants lost to follow-up</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in diet as assessed by qualitative review of foods logs</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will maintain weekly food logs</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in diet as assessed by response to survey questions</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will respond to exploratory survey questions about diet created by the study team.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in physical symptoms</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Participants will respond to exploratory survey questions about physical symptoms created by the study team.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>PreDiabetes</condition>
  <arm_group>
    <arm_group_label>Low-Carbohydrate Diabetes Prevention Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At least 20 individuals with prediabetes will participate in a year-long , group-based program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low-Carbohydrate Diabetes Prevention Program</intervention_name>
    <description>LC-DPP participants will be instructed to follow ad-libitum very low-carbohydrate, ketogenic diet, which restricts carbohydrate intake (not including fiber) to 20-35 grams per day with the goal of achieving nutritional ketosis. Participants will be encouraged to eat a normal amount of protein (roughly 80-120 grams per day) and to derive the remaining calories from fat. Allowable foods include: meats, fish, poultry, eggs, cheese, seeds, nuts, leafy greens, non-starchy vegetables, and some fruits.</description>
    <arm_group_label>Low-Carbohydrate Diabetes Prevention Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Overweight, defined as BMIâ‰¥25 kg/m2 [31]

          2. HbA1c between 5.7-6.4% drawn within 6 months of the study start date

          3. Willingness to participate in group-based classes

          4. Able to engage in at least light physical activities such as walking.

        Exclusion criteria:

          1. History of type 1 diabetes or type 2 diabetes

          2. Current participation in another lifestyle or behavior change program or research
             study

          3. Vegetarian or vegan lifestyle

          4. History of bariatric surgery

          5. Inability to read, write, or speak English

          6. Inability to provide informed consent

          7. Women who are pregnant or intend to become pregnant during the intervention period.

          8. Insured by Premier Care or Grad Care; these individuals have the opportunity to
             participate in a standard DPP, which is offered as a covered benefit through their
             health plan.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Michigan Medicine</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2017</study_first_submitted>
  <study_first_submitted_qc>August 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Dina Griauzde, Internal Medicine</investigator_full_name>
    <investigator_title>Clinical Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

